BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 11274623)

  • 1. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
    N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
    Sung JJ; Chung SC; Ling TK; Yung MY; Leung VK; Ng EK; Li MK; Cheng AF; Li AK
    N Engl J Med; 1995 Jan; 332(3):139-42. PubMed ID: 7800005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
    Chan FK; Hung LC; Suen BY; Wu JC; Lee KC; Leung VK; Hui AJ; To KF; Leung WK; Wong VW; Chung SC; Sung JJ
    N Engl J Med; 2002 Dec; 347(26):2104-10. PubMed ID: 12501222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
    N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
    Lai KC; Lam SK; Chu KM; Wong BC; Hui WM; Hu WH; Lau GK; Wong WM; Yuen MF; Chan AO; Lai CL; Wong J
    N Engl J Med; 2002 Jun; 346(26):2033-8. PubMed ID: 12087138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
    N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H; Polson RJ
    Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study.
    Befrits R; Sjöstedt S; Tour R; Leijonmarck CE; Hedenborg L; Backman M;
    Scand J Gastroenterol; 2004 Nov; 39(11):1066-72. PubMed ID: 15545163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection.
    Hsieh YH; Lin HJ; Tseng GY; Perng CL; Chang FY; Lee SD
    Hepatogastroenterology; 2001; 48(40):1078-81. PubMed ID: 11490804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole.
    Bannwarth B; Dorval E; Caekaert A; Barthelemy P
    J Rheumatol; 2002 Sep; 29(9):1975-80. PubMed ID: 12233895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.